Phosphorylation of PML is essential for activation of C/EBPe and PU.1 to accelerate granulocytic differentiation

Leukemia

Volumn 22, Issue 2, 2008, Pages 273-280

  Tagata, Y ^a,b   Yoshida, H ^a   Nguyen, L A ^a   Kato, H ^a,b   Ichikawa, H ^a   Tashiro, F ^b   Kitabayashi, I ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN EPSILON; GRANULOCYTE COLONY STIMULATING FACTOR; MUTANT PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN P300; SERINE; TRANSCRIPTION FACTOR PU 1;

ARTICLE; BONE MARROW CULTURE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; GRANULOCYTE; GRANULOPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 39149129985     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2405024     Document Type: Article

References (20)

1. Zhong S, Salomoni P, Pandolfi PP. The transcriptional role of PML and the nuclear body. Nat Cell Biol 2000; 2: E85-E90.
2. de The H, Chomienne C, Lanotte M, Degos L, Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990; 347: 558-561.
3. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C et al Role of PML in cell growth and the retinoic acid pathway. Science 1998; 279: 1547-1551.
4. Kastner P, Lawrence HJ, Waltzinger C, Ghyselinck NB, Chambon P, Chan S. Positive and negative regulation of granulopoiesis by endogenous RARalpha. Blood 2001; 97: 1314-1320.
5. Muller S, Matunis MJ, Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 1998; 17: 61-70.
6. Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP. PML regulates p53 stability by sequestering Mdm2 to the nucleolus. Nat Cell Biol 2004; 6: 665-672.
7. Yang S, Kuo C, Bisi JE, Kim MK. PML-depenclent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2. Nat Cell Biol 2002; 4: 865-870.
8. Hayakawa F, Privalsky ML. Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis. Cancer Cell 2004; 5: 389-401.
9. Scaglioni PP, Yung TM, Cai LF, Erdjument-Bromage H, Kaufman AJ, Singh B et al. A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 2006; 126: 269-283.
10. Nguyen LA, Pandolfi PP, Aikawa Y, Tagata Y, Ohki M, Kitabayashi I. Physical and functional link of the leukemia-associated factors AML1 and PML. Blood 2005; 105: 292-300.
11. Lekstrom-Himes JA. The role of C/EBPεin the terminal stages of granulocyte differentiation. Stem Cells 2001; 19: 125-133.
12. Fisher RC, Scott EW. Kole of PU.1 in hematopoiesis. Stem Cells 1998; 116: 25-37.
13. Yoshida H, Ichikawa H, Tagata Y, Katsumoto T, Ohnishi K, Akao Y et al PML-RAPA inhibits PML IV enhanrement of PU.1-induced C/EBPε expression in myeloid differentiation. Mol Cell Biol 2007; 16 5819-5834.
14. Kinashi T, Lee K, Ogawa M, Tohyama K, Tashiro K, Fukunaga R et al. Premature expression of the macrophage colony-stimulating factor receptor on a multipotential stem cell line does not alter differentiation lineages controlled by stromal cells used for coculture. J Exp Med 1991; 173 1267-1279.
15. Shimizu K, Kitabayashi I, Kamada N, Abe T, Maseki N, Suzukawa K et al AML1-MTG8 leukemic protein induces the expression of granulocyte colony-stimulating factor (G-CSF) receptor through the up-regulation of CCAAT/enhancer binding protein epsilon. Blood 2000; 96: 288-296.
16. Kakizuka A, Miller Jr WH, Umesono K, Warrell Jr RP, Frankel SR, Murty VV et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663-674.
17. Nakajima H, Ihle JN. Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein epsilon. Blood 2001; 98: 897-905.
18. Verbeek W, Lekstrom-Himes J, Park DJ, Dang PM, Vuong PT, Kawano S et al. Myeloid transcription factor C/EBPε is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood 1999; 94: 3141-3150.
19. Engelhardt OG, Boutell C, Orr A, Ullrich E, Haller O, Everett RD. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML. Exp Cell Res 2003; 283 36-50.
20. Aikawa Y, Nguyen LA, Isono K, Takakura N, Tagata Y, Schmitz ML et al Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J 2006; 25: 3955-3965.